Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
5,970 total articles
Crexendo ($CXDO) just cleared its 52-week high on heavy volume, beating short-term sellers and re-rating on growth and cash flow. The business is small but profitable, and recent price action creates a defined trade: enter at the market, protect with a tight stop under near-term support, and target a gain that pays well for the risk taken.
We upgrade Expedia (EXPE) to a buy for a mid-term trade. Despite region-specific travel disruptions, ADR expansion and product distribution gains are lifting revenue and booking value. The company trades on attractive free cash flow multiples, has a manageable balance sheet, and is showing improving retail momentum. Entry at $223.44, target $260, s…
Advantage Oil & Gas (AAVVF) trades near $7.08 with a market cap of roughly $1.37B and a price-to-book of ~0.65. The stock is cheaply valued relative to book, has seen accelerating short interest, and shows early bullish technical signals (MACD turning positive, RSI ~40). This trade idea proposes a defined long swing: entry $7.05, stop $6.40, target…
JOYY ripped higher on heavy volume after a positive outlook surprise and now trades at a modest P/E of 13 and a sub-0.5 P/B while yielding roughly 7.8%. The combination of value, cash returns, and bullish momentum supports a mid-term long trade to capture reversion toward the 52-week high and beyond, while keeping a tight stop below the 50-day area…
Micron’s stock has ripped higher to a record price and a >$1 trillion market cap on fresh AI demand and a dramatic UBS price-target hike. Fundamentals show strong cash generation and healthy balance-sheet metrics, while technicals and ETF flows amplify momentum. This is a trade idea to ride the mid-term AI-driven memory rally with a clear entry, st…
Tencent (TCEHY) is trading near its 52-week low while fundamentals and strategic positioning remain intact. With a market cap around $512B, a PE of 15.4, and signs of oversold momentum, this pullback offers a favorable risk-reward for a mid-term long trade. Entry, stop and target are laid out with catalysts and conservative risk controls.
Nano Labs (NA) trades like a busted growth story at a $60.8M market cap, yet the company has a cheap P/E of 2.6, a CEO who bought shares, ongoing AI/data-center related partnerships and a pivot toward crypto reserves that materially improved cash posture. Technicals show improving momentum and short interest is significant — creating potential sque…
Iamgold reported a blockbuster operational quarter and generated $525M in free cash flow, driving revenue to $1.0B and EBITDA to $666M. The market values the company at roughly $10.17B, implying an attractive multiple relative to the recent cash print. We recommend a tactical long entry at $16.00 (wait for the pullback), target $22.00 and stop $14.…
NVIDIA remains the dominant play on accelerated compute for AI. Fundamentals — including $119B of trailing free cash flow, 82% ROE and a $5.26T market cap — support further upside despite premium multiples. We upgrade to Buy with a clear entry, stop and target and a 180-trading-day time horizon.
Apple is positioned to convert its massive installed base, custom silicon and services ecosystem into a powerful AI-driven profit cycle. This trade targets a measured gain on the thesis that AI-enabled features and new monetization will accelerate services revenue and expand gross margins over the next 6 months.
Freshworks is showing 16% revenue growth, improving profitability, positive free cash flow and product momentum tied to AI-enabled service automation. Valuation at roughly $2.6B and a P/E near 14 looks reasonable given the operational tailwinds. We outline a mid-term swing trade plan (45 trading days) to capture upside as adoption of Freddy AI and …
SpaceX's increasing investment in in-house AI capabilities looks set to shift demand from bespoke aerospace hardware to datacenter compute. That change favors public companies that dominate AI accelerators. This trade targets Nvidia as the most direct public beneficiary, with clear entry, stop and target levels and a 180-trading-day horizon.
Kimberly-Clark offers a 5.1% yield, $1.28 quarterly dividend, and $1.84B in free cash flow against a $33B market cap. With a P/E near 15.6 and improving technicals, this dividend aristocrat is set up to recover as acquisition fears normalize and H2 catalysts approach. Trade plan included for a long position over the next 180 trading days.
CytomX has materially strengthened its balance sheet via a $250M equity offering and is approaching two high-profile healthcare conferences in early June where management will present program updates. The stock is still cheap on an enterprise-value-to-revenue basis only because revenues are very small; the trade is a tactical long that leans on cas…
Apple’s stock is trading at fresh highs as iPhone demand remains firm and services/free cash flow remain a structural tailwind. Technical momentum is strong but stretched; this trade targets a measured breakout with a defined stop and realistic upside over a mid-term horizon.
Amazon's pullback into the mid-$260s creates an asymmetric trade: the core cloud advertising retail cash machine is still growing, AWS is expanding margins, and the balance sheet remains conservative. For disciplined traders who size positions and use a hard stop, the risk/reward favors an entry now for a long-term (180 trading days) trade to $320.
Lumentum (LITE) has been one of 2026’s breakout beneficiaries of the AI infrastructure cycle. After a steep run and a recent pullback from a May high, the stock is offering a tradeable setup: enter on signs of momentum resumption, use a disciplined stop under technical support, and target the prior 52-week high while monitoring valuation and custom…
Retail chatter suggests Meta is overextended, but the company’s advertising ARPU and cash flow profile argue for a tactical long. Valuation is reasonable relative to cash flow and profitability; a measured long with a tight stop can capture re-rating if AI-driven ARPU momentum continues.
Micron's stock is pricing a lot of the AI upside, but underlying fundamentals and industry supply dynamics still leave room for a continued move higher. Strong Q2 revenue prints, robust free cash flow, and low leverage give Micron the balance-sheet durability to capture AI-driven demand for HBM, DRAM, and NAND. Technical momentum and low days-to-co…
The Joint Corp. (JYNT) is actively shrinking its corporate footprint and accelerating refranchising. With a market cap of roughly $129M, low net debt, positive free cash flow and a franchise model that scales, the stock offers asymmetric upside if management executes. This trade idea lays out an actionable long with entry, stop and target, the rati…
Ford has momentum from a new Ford Energy unit and cost actions, but fundamentals and technicals suggest recent gains leave limited upside versus risk. My trade: wait for a pullback to $12.00 (roughly a 5% dividend yield), place a disciplined stop at $11.00, and target $15.00 over a long-term (180 trading days) holding period. That entry offers a fa…
Nvidia remains the dominant AI infrastructure provider with a market cap north of $5 trillion, strong free cash flow and expanding product scope into CPUs. Valuation looks rich but earnings momentum and product catalysts justify a tactical long. Trade plan: enter at $218.13, stop $195.00, target $270.00 over a mid-term (45 trading days) horizon.
Arqit (ARQQ) is a speculative long with a clear path to a turnaround: recent telecom and DoD wins plus a Vodafone partnership create a plausible revenue cadence that can re-rate the stock from its $256M market cap. I upgrade my rating and recommend a long trade with defined entry, stop and target.
Nvidia looks set for another leg higher if it clears the near-term technical hurdles. Fundamentals remain stellar and fresh product/cpu catalysts create a clear path; this trade spells out an entry at $220, stop at $205 and a $245 target over a mid-term (45 trading days) horizon.
Amgen combines strong free cash flow, a durable dividend, and growing exposure to high-growth modalities (oligonucleotides and cardiovascular indications). At $338, the stock offers a risk/reward setup into clear near-term and medium-term catalysts while valuation metrics remain reasonable for a cash-rich biotech. Long-term (180 trading days) trade…
